PharmaCyte Biotech Inc. (PMCB)
NASDAQ: PMCB
· Real-Time Price · USD
1.02
0.01 (0.99%)
At close: Aug 19, 2025, 1:54 PM
PharmaCyte Biotech Balance Sheet Statement
Financials in USD. Fiscal
year is
May - April.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 |
Cash & Equivalents | 15.17M | 16.38M | 20.84M | 32.64M | 50.18M | 61.21M | 73.43M | 74.66M | 68.04M | 72.64M | 76.96M | 82.23M | 85.4M | 86.64M | 86.94M | 959.27K | 2.2M | 3.09M | 3.72M | 2.17M |
Short-Term Investments | 366.32K | 372.63K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 22.47M | 25.31M | 24.86M | 29.12M | 7.91M | 6.29M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M |
Other Long-Term Assets | 8.77M | 7.69K | 7.36M | 6.65M | 7.69K | 7.69K | 7.69K | 7.69K | 7.69K | 7.69K | 7.69K | 7.69K | 7.69K | 7.69K | 7.69K | 7.37K | 7.37K | 7.37K | 7.37K | 7.37K |
Receivables | 3.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.14M | 207.36K | 493.21K | 240.23K | 259.8K | 297.76K | 323.19K | 88.65K | 107.68K | 181.01K | 256.81K | 28.15K | 94.17K | 174.1K | 241.8K | 549.09K | 73.13K | 41.71K | 94.96K | 136.54K |
Total Current Assets | 22.38M | 16.96M | 21.33M | 32.88M | 50.44M | 61.51M | 73.75M | 74.75M | 68.15M | 72.82M | 77.22M | 82.26M | 85.49M | 86.81M | 87.18M | 1.51M | 2.28M | 3.13M | 3.81M | 2.3M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | 1.55M | 1.55M | 1.55M | 1.55M | 1.55M | 3.55M | 3.55M | 3.55M | 3.55M | 3.55M | 3.55M | 3.55M | 3.55M | 3.55M | 3.55M | 3.55M | 3.55M | 3.55M | 3.55M | 3.55M |
Total Long-Term Assets | 32.79M | 26.87M | 33.77M | 37.32M | 9.46M | 9.85M | 5.13M | 5.13M | 5.13M | 5.13M | 5.13M | 5.13M | 5.13M | 5.13M | 5.13M | 5.13M | 5.13M | 5.13M | 5.13M | 5.13M |
Total Assets | 55.17M | 43.83M | 55.1M | 70.19M | 59.9M | 71.36M | 78.88M | 79.88M | 73.28M | 77.95M | 82.35M | 87.39M | 90.62M | 91.94M | 92.31M | 6.64M | 7.4M | 8.26M | 8.94M | 7.43M |
Account Payables | 399.2K | 484.95K | 348.6K | 553.95K | 389.37K | 484.2K | 126.16K | 718.13K | 128.28K | 445.94K | 861.28K | 559.03K | 205.36K | 92.86K | 157.04K | 394.77K | 172.26K | 79.16K | 80.12K | 384.83K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12.79K | -50.8K | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.79K | 50.8K | 66.75K | 54.11K | 41.5K |
Other Current Liabilities | n/a | 709.44K | 4.08M | 6.74M | 6.73M | 6.9M | 4.96M | 665.25K | 345.41K | 292.2K | 383.36K | 381.75K | 380.95K | 470.01K | 1.98K | 7.62K | n/a | 9.88K | 43.31K | 282.91K |
Total Current Liabilities | 2.91M | 1.19M | 4.78M | 7.47M | 7.42M | 7.54M | 5.24M | 1.52M | 586.58K | 827.83K | 1.31M | 1.09M | 704.37K | 612.98K | 186.12K | 924.97K | 724.78K | 640.25K | 643.65K | 1.15M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.45K | 21.09K | 33.7K |
Other Long-Term Liabilities | 363K | 2.38M | 6.87M | 9.68M | 12.97M | 14.93M | 15.57M | 18.88M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 363K | 2.38M | 6.87M | 9.68M | 12.97M | 14.93M | 15.57M | 18.88M | n/a | 445.94K | 861.28K | n/a | 205.36K | 92.86K | 157.04K | n/a | n/a | 8.45K | 21.09K | 33.7K |
Total Liabilities | 3.28M | 3.58M | 11.65M | 17.15M | 20.39M | 22.47M | 20.81M | 20.4M | 586.58K | 827.83K | 1.31M | 1.09M | 704.37K | 612.98K | 186.12K | 924.97K | 724.78K | 648.7K | 664.74K | 1.19M |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.79K | 50.8K | 75.2K | 75.2K | 75.2K |
Common Stock | 2.17K | 2.17K | 2.17K | 2.17K | 2.17K | 2.17K | 2.17K | 2.17K | 2.16K | 2.16K | 2.16K | 2.16K | 2.07K | 2.07K | 2.07K | 161.00 | 159.00 | 234.14K | 233.48K | 187.51K |
Retained Earnings | -84.97M | -96.72M | -93.67M | -92.2M | -115.63M | -116.97M | -116.35M | -119.46M | -115.96M | -115.84M | -115.07M | -113.19M | -111.65M | -110.23M | -109.41M | -108.43M | -107.41M | -106.45M | -105.69M | -104.74M |
Comprehensive Income | -23.87K | -24.49K | -23.27K | -23.33K | -23.51K | -23.07K | -24.14K | -22.55K | -23K | -17.73K | -15.17K | -14.45K | -15.76K | -19.3K | -19.09K | -22K | -20.38K | -21.02K | -21.88K | -19.03K |
Shareholders Equity | 51.89M | 40.25M | 43.45M | 53.04M | 39.51M | 48.89M | 58.07M | 59.48M | 72.69M | 77.12M | 81.04M | 86.3M | 89.92M | 91.33M | 92.12M | 5.71M | 6.68M | 7.61M | 8.28M | 6.25M |
Total Investments | 22.84M | 25.68M | 24.86M | 29.12M | 7.91M | 6.29M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M | 1.57M |